Orchestra BioMed Holdings (OBIO) Other Non-Current Assets (2020 - 2026)

Orchestra BioMed Holdings' (OBIO) quarterly Other Non-Current Assets came in at $1.3 million in Q1 2026, down 1.56% year-on-year from $1.3 million in Q1 2025, and up 1.94% on a QoQ basis from $1.2 million in Q4 2025.

Orchestra BioMed Holdings (OBIO) Other Non-Current Assets (2020 - 2026) Analysis & Trends

Orchestra BioMed Holdings (OBIO) has 6 years of Other Non-Current Assets data on file, last reported at $1.3 million in Q1 2026.

  • On a quarterly basis, Other Non-Current Assets fell 1.56% year-over-year to $1.3 million in Q1 2026; TTM through Mar 2026 was $1.3 million, a 1.56% decrease from a year earlier, with the FY2025 full-year figure at $1.2 million, up 21.57% from the prior year.
  • Other Non-Current Assets for Q1 2026 stood at $1.3 million, up from $1.2 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for OBIO reached as high as $4.7 million in Q4 2022 and fell as low as $421000.0 in Q1 2023.
  • Historically, Other Non-Current Assets has averaged $1.2 million across 5 years, with a median of $1.1 million in 2024.
  • Across the five-year window, Other Non-Current Assets slumped 83.68% in 2023 and soared 115.73% in 2024, its largest moves.
  • Year by year, Other Non-Current Assets stood at $4.7 million in 2022, then slumped by 83.68% to $769000.0 in 2023, then soared by 32.64% to $1.0 million in 2024, then climbed by 21.57% to $1.2 million in 2025, then climbed by 1.94% to $1.3 million in 2026.
  • Per Business Quant data, the three most recent Other Non-Current Assets figures were $1.3 million in Q1 2026, $1.2 million in Q4 2025, and $1.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 1.02 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 104.24 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.26 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 2.13 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 124.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 14.48 Mn
10 Orchestra BioMed Holdings 228.31 Mn 143.68 Mn 78,000.00 1.26 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.26 Mn
Dec 31, 2025 1.24 Mn
Sep 30, 2025 1.30 Mn
Jun 30, 2025 1.28 Mn
Mar 31, 2025 1.28 Mn
Dec 31, 2024 1.02 Mn
Sep 30, 2024 1.30 Mn
Jun 30, 2024 841,000.00
Mar 31, 2024 894,000.00
Dec 31, 2023 769,000.00
Sep 30, 2023 604,000.00
Jun 30, 2023 517,000.00
Mar 31, 2023 421,000.00
Dec 31, 2022 4.71 Mn
Dec 31, 2020 162.16 Mn